Real Life Sciences Japan to attend 19th International Conference of Pharmaceutical Medicine (ICPM)

Real Life Sciences Japan will be exhibiting at ICPM 2018 and we are excited to see what is in store for the booming pharma space in Japan.

The theme for this year is ‘The Future of Medicines Development’.

Japan possess one of the most successful medical industries in the world. However, with its fast aging population, it is likely to drive the demand for medicine in the years to come.

ICPM 2018 will highlight the markets that are growing within pharma to meet the escalating demands for new and improved drugs, devices and services.

 

What can you look out for?

Pharmaceutical Medicine and Clinical Research

Japan continues to be one of the largest pharmaceutical markets in the world despite the challenging business landscape due to demographics. According to the latest official figures from the Ministry of Health, Labour and Welfare (MHLW)’s Annual Pharmaceutical Production Statistics, the Japanese market for prescription and non-prescription pharmaceuticals in 2017 have summed up to $95 billion (up 2.3% from 2016 in yen terms).

Pharmacovigilance

Japan’s Pharmacovigilance is the process and science of monitoring the safety of medication and taking action to reduce the risks whilst increase the benefits of medication. Currently, medicinal products manufactured in Japan are subject to a strict testing to enhance the assessment of their quality, efficacy and safety before being authorised.

Big data in Medicine’s Development

The current environment for health and medical data in Japan are in siloes – for instance, by type of disease, service provider or region. It is seen to be less cost effective to collect data which are large and deep enough to spin-off the development of new drugs or measure the effectiveness of new treatments. However, this is a trend that would likely change in the coming years.

Artificial Intelligence

More pharma companies in Japan are starting to venture into areas such as AI in drug discovery, health services and even medical devices. With the aging population, AI serves as a support and form of assistance to ease the burden in shortage of medical practitioners and specialists, along with pharma manufacturers.

 

When is ICPM 2018 happening?

Date: September 27 (Thursday) - 29 (Saturday)

Venue: The University of Tokyo Ito International Academic Research Center (for 27th – 28th), Tokyo University of Medical Education and research building Tetsumon Memorial Auditorium (29th )

Our Booth number: 4

The pharma and medical sector is currently undergoing great changes in Japan. To get updated on the latest industry trends as well as contribute to the industry in terms of talent insights, Real Life Sciences Japan will be having a booth at this much anticipated event. If you’d like to find out more, get connected with us at [email protected] for more updates. You may also visit our website at www.realstaffing.com for more industry related insights. For more information about the event, do also visit https://www.icpm2018tokyo.com/message.html.

Keep a look out for more updates closer to the event and we hope to see you there!

Are there enough women in pharma?

18 Feb 2020

We had a chat with Sharlyn Soh and Dinah Yazid, Recruitment Consultants from Real Life Sciences Singapore who shared their take on having women step up in different pharma markets.

Tags: APAC

5 Professional Goals you should have for 2020

01 Jan 2020

It is the time of the year again to ponder over New Year resolutions. While various critics have suggested that only a minority of people who make resolutions stick to them, realistic and practical goals are achievable if you put your mind to it.

SThree COVID-19 Update

19 Mar 2020

Our purpose is to bring skilled people together to build the future, and this has never felt more important than it does today

Are there more opportunities in South Korea’s medical scene following the government’s ₩500b investment?

10 Jul 2019

South Korea’s government spending has always played a crucial role in boosting the economy. How will this investment help in creating more jobs and encouraging innovation that can contribute to the country’s sustainable growth?